Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Neuroendocrine Tumors × Capecitabine × Clear all

Sponsor

Conditions

Breast Neoplasms 6 Stomach Neoplasms 3 Neoplasms 2 Neoplasm Metastasis 2 Rectal Neoplasms 1 Rectal Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Intestinal Neoplasms 1 Intestinal Diseases 1 HER2+ Metastatic Breast Cancer (MBC) 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Digestive System Neoplasms 1 Digestive System Diseases 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Colonic Diseases 1 Brain Neoplasms 1 Adenocarcinoma Of Esophagus 1 Adenocarcinoma 1

Interventions

repotrectinib 1 pralsetinib 1 pembrolizumab 1 lutetium Lu 177 dotatate 1 entrectinib 1 cabozantinib 1 X-Rays 1 Specimen Handling 1 Phantoms, Imaging 1 Octreotide 1 Magnetic Resonance Spectroscopy 1 3-Iodobenzylguanidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡